Search

Search Results

15 results found. Results per page: [ 20 ] [ 40 ] [ 60 ] [ 80 ] [ 100 ] [ 200 ] [ 300 ]

Sort by: [ Publication Date ] [ Score ]

Direction: [ Desc ] [ Asc ]

Year of publication: [ 2026 ] [ 2025 ] [ 2024 ] [ 2023 ] [ 2022 ] [ 2021 ] [ 2020 ] [ 2019 ] [ 2018 ] [ 2017 ] [ 2016 ] [ 2015 ] [ 2014 ] [ 2013 ] [ 2012 ] [ 2011 ] [ 2010 ] [ 2009 ] [ Any ]

• Research PapersVolume 13, Issue 0pp 44-54

  Tumor-informed liquid biopsy detection of structural variants in high grade serous ovarian cancer

  Relevance score: 0.00

  Jian Li, Shiro Takamatsu, Allison L. Brodsky, Thomas Welte, Katherine Calzoncinth, Veena K. Vuttaradhi, Joseph Celestino, Barrett Lawson, R. Tyler Hillman

  Keywords: ovarian cancer; ctDNA; biomarker; liquid biopsy; structural variant

  Published in Aging on March 4, 2026

  Show abstract
• EditorialsVolume 10, Issue 0pp 9-10

  UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?

  Relevance score: 0.00

  Melisa Husein, Patrick Petignat, Marie Cohen

  Keywords: ovarian cancer; polyploidy giant cancer cell; unfolded protein response; drug resistance

  Published in Aging on May 11, 2023

• Research PapersVolume 2, Issue 3pp 294-308

  P18/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxane

  Relevance score: 0.00

  Mohamed Kamel Hassan, Hidemichi Watari, Takashi Mitamura, Zainab Mohamed, Sherif F. EL-khamisy, Yusuke Ohba, Noriaki Sakuragi

  Keywords: ovarian cancer, chemoresistance, miR-31, taxane, Stathmin 1

  Show abstract
• Research PapersVolume 2, Issue 4pp 373-381

  Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer

  Relevance score: 0.00

  Isabella Monia Montagner, Anna Merlo, Debora Carpanese, Gaia Zuccolotto, Davide Renier, Monica Campisi, Gianfranco Pasut, Paola Zanovello, Antonio Rosato

  Keywords: ovarian cancer, tumor targeting, SN-38, hyaluronan, bioconjugate

  Show abstract
• EditorialsVolume 3, Issue 31pp 308-310

  A miRNA signature assessing ovarian cancer prognosis

  Relevance score: 0.00

  Marina Bagnoli, Sandro Pignata, Delia Mezzanzanica

  Keywords: ovarian cancer; microRNA; MITO translational

• Research PerspectivesVolume 6, Issue 47pp 349-350

  H2Bub1: Guardian of Chromatin Accessibility in Ovarian Cancer

  Relevance score: 0.00

  Hunter Reavis, Ronny Drapkin

  Keywords: Fallopian tube; ovarian cancer; RNF20; H2Bub1; chromatin

  Published in Aging on August 23, 2109

• EditorialsVolume 3, Issue 4pp 145-146

  The role of BRCA1-IRIS in ovarian cancer formation, drug resistance and progression

  Relevance score: 0.00

  Wael M. ElShamy

  Keywords: BRCA1-IRIS, ovarian cancer, anoikis, therapy

• Research PapersVolume 1, Issue 1pp 5-13

  MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors

  Relevance score: 0.00

  Chad Tang, Denis L. Fontes Jardim, Gerald S. Falchook, Kenneth Hess, Siqing Fu, Jennifer J. Wheler, Ralph G. Zinner, Aung Naing, Apostolia M. Tsimberidou, Debora De Melo Galgiato, Shannon N. Westin, Funda Meric-Bernstam, Razelle Kurzrock, David S. Hong

  Keywords: MET nucleotide variations, MET amplification, ovarian cancer, c-Met inhibitor

  Show abstract
• Research PapersVolume 1, Issue 3pp 216-228

  Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor

  Relevance score: 0.00

  Georgia A. McCann, Shan Naidu, Kellie S. Rath, Hemant K. Bid, Brent J. Tierney, Adrian Suarez, Saradhadevi Varadharaj, Jianying Zhang, Kalman Hideg, Peter Houghton, Periannan Kuppusamy, David E. Cohn, Karuppaiyah Selvendiran

  Keywords: Hypoxia, STAT3, Ovarian Cancer, HO-3867, Chemo-resistance

  Show abstract
• EditorialsVolume 2, Issue 12pp 942-943

  Nucleotide excision repair (NER) alterations as evolving biomarkers and therapeutic targets in epithelial cancers

  Relevance score: 0.00

  Kent W. Mouw, Alan D. D'Andrea, Pangiotis A. Konstantinopoulos

  Keywords: Nucleotide excision repair (NER), ovarian cancer

• Research PapersVolume 1, Issue 1pp 21-29

  Disulfiram/copper causes redox-related proteotoxicity and concomitant heat shock response in ovarian cancer cells that is augmented by auranofin-mediated thioredoxin inhibition

  Relevance score: 0.00

  Margarita Papaioannou, Ioannis Mylonas, Richard E. Kast, Ansgar Bruning

  Keywords: drug repurposing, proteotoxicity, disulfiram, auranofin, heat shock response, heat shock proteins, ovarian cancer

  Show abstract
• Case ReportsVolume 12, Issue 0pp 70-78

  A rare case of pure non-gestational ovarian choriocarcinoma: Diagnostic mimicry and management strategies

  Relevance score: 0.00

  Naina Kumar, Abhishek Arora, Gunvanti Rathod, Mishu Mangla, Aparna Setty, Pooja T. Rathod, Banka Sai Swetha

  Keywords: chemotherapy; ectopic pregnancy; germ cell tumor; gestational ovarian choriocarcinoma; non-gestational ovarian choriocarcinoma

  Published in Aging on July 28, 2025

  Show abstract
• EditorialsVolume 2, Issue 10pp 793-794

  Elafin: a double agent in breast and ovarian cancer

  Relevance score: 0.00

  Yi Feng, Kai Doberstein, Ronny Drapkin

  Keywords: Elafin, high-grade serous ovarian carcinoma

  Published in Aging on September 17, 2015

• Research PerspectivesVolume 1, Issue 9pp 574-579

  Epigenetic and genetic dispositions of ovarian carcinomas

  Relevance score: 0.00

  Ken Yamaguchi, Noriomi Matsumura, Masaki Mandai, Tsukasa Baba, Ikuo Konishi, Susan K. Murphy

  Keywords: epigenetics, methylation, high-grade serous adenocarcinoma, ovarian clear cell carcinoma

  Show abstract
• EditorialsVolume 2, Issue 8pp 671-672

  Targeting ncRNAs in the 3q26.2 amplicon

  Relevance score: 0.00

  Pradeep Chaluvally-Raghavan, Gordon B. Mills

  Keywords: CNA, microRNA, miR-therapy, TP53INP1, ovarian